MAM
WVE icon

Meeder Asset Management’s Wave Life Sciences WVE Stock Holding History

Meeder Asset Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-260
Closed – – 2373
2021
Q3 		$0 Sell
260
-1,927
-88% -$11.7K ﹤0.01% 2658
2021
Q2 		$15K Sell
2,187
-1,415
-39% -$9.25K ﹤0.01% 1569
2021
Q1 		$20K Buy
+3,602
New +$34.6K ﹤0.01% 1410
2020
Q4 		– Sell
-600
Closed -$5K – 2255
2020
Q3 		$5K Buy
600
+159
+36% +$1.74K ﹤0.01% 1604
2020
Q2 		$4K Sell
441
-1,024
-70% -$9.63K ﹤0.01% 1620
2020
Q1 		$14K Buy
+1,465
New +$12.5K ﹤0.01% 1382
2019
Q2 		– Sell
-301
Closed -$12K – 2161
2019
Q1 		$12K Sell
301
-42
-12% -$1.7K ﹤0.01% 1203
2018
Q4 		$15K Buy
+343
New +$15.3K ﹤0.01% 1148
2018
Q2 		– Sell
-29
Closed -$1K – 1696
2018
Q1 		$1K Buy
29
+27
+1,350% +$1.14K ﹤0.01% 1488
2017
Q4 		$0 Buy
+2
New +$58 ﹤0.01% 1818
2017
Q2 		– Sell
-66
Closed -$2K – 1904
2017
Q1 		$2K Buy
+66
New +$1.84K ﹤0.01% 1416

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Meeder Asset Management's WVE Position: Q4 2021 in Review

Meeder Asset Management sold out of Wave Life Sciences (WVE) in Q4 2021, closing a stake of 260 shares.

Meeder Asset Management first reported a position in WVE in Q1 2017 and held it in 11 quarters. The position peaked at $20K in Q1 2021. 90 funds tracked by Wall St. Rank hold WVE as of Q4 2021.

  • Meeder Asset Management reported no remaining Wave Life Sciences position as of Q4 2021 after selling out during the quarter.
  • Meeder Asset Management sold 260 Wave Life Sciences shares in Q4 2021.
  • Meeder Asset Management first reported a position in Wave Life Sciences in Q1 2017 and held it in 11 quarters.
  • Meeder Asset Management's Wave Life Sciences position peaked at $20K in Q1 2021.
  • 90 funds tracked by Wall St. Rank held Wave Life Sciences as of Q4 2021.

Based on Meeder Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.